Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future
Open Access
- 14 March 2016
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (22) , 33461-33471
Abstract
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureKeywords
This publication has 103 references indexed in Scilit:
- Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator systemCell Research, 2013
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidisProceedings of the National Academy of Sciences, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- A transcription activator-like effector toolbox for genome engineeringNature Protocols, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coliNucleic Acids Research, 2011
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine gliomaProceedings of the National Academy of Sciences, 2011
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcriptionNature Biotechnology, 2011
- BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastasesOncogene, 2009
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007